This meta-analysis studies the development of COVID-19 (SARS COV-2) targeting drugs, their similarities in structure, and how that impacts the development of such drugs. Although it is already 2025, with the United States no longer being in a state of emergency, it is important to retroactively look at the development of novel drugs from 2020, in order to prevent similar pandemics from happening in the future.